v3.26.3
Stock-Based Compensation (Tables)
9 Months Ended
Sep. 30, 2026
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Equity Awards Granted

The following table summarizes the equity awards granted during the three and nine months ended September 30, 2026 and 2025:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Equity Awards Granted

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock awards (shares)

 

 

—

 

 

 

—

 

 

 

132,735

 

 

 

22,140

 

Stock options (shares)

 

 

—

 

 

 

92,000

 

 

 

20,000

 

 

 

1,029,358

 

Average exercise price (options)

 

$

—

 

 

$

7.28

 

 

$

6.33

 

 

$

12.88

 

Restricted stock units (RSUs)

 

 

70,000

 

 

 

—

 

 

 

148,749

 

 

 

—

 

Schedule of Stock-Based Compensation Expense

The following table summarizes stock-based compensation expense during the three and nine months ended September 30, 2026 and 2025:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

 

(in thousands)

 

Stock based compensation expense

 

$

861

 

 

$

729

 

 

$

2,429

 

 

$

2,338

 

Schedule of Share Issued

The following table summarizes shares of Common Stock issued pursuant to equity awards under the Plan during the three and nine months ended September 30, 2026 and 2025:

 

 

Three Months Ended
September 30,

 

 

Nine Months Ended
September 30,

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

Shares Issued

 

 

 

 

 

 

 

 

 

 

 

 

Restricted stock vesting

 

 

-

 

 

 

-

 

 

 

116,919

 

 

 

17,921

 

Stock option exercises (1)

 

 

-

 

 

 

82,520

 

 

 

215,730

 

 

 

104,530

 

Total shares issued

 

 

-

 

 

 

82,520

 

 

 

332,649

 

 

 

122,451

 

(1) Stock option proceeds of $30,000 reflected in the Condensed Consolidated Statements of Shareholders’ Equity for the three months ended September 30, 2026 relate to exercises that occurred in the second quarter of 2026. See the Condensed Consolidated Statements of Shareholders' Equity.